StockWatch
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Quarterly ResultAug 4, 2026, 05:33 PM

Integer Q2 Sales Down 2.6% to $464.1M; Net Income $23.6M

AI Summary

Integer Holdings Corp reported Q2 2026 sales of $464.1 million, a 2.6% decrease from Q2 2025, with net income falling 36.2% to $23.6 million. For the first six months of 2026, net income significantly increased to $40.1 million, primarily due to the absence of prior year's debt conversion inducement expenses and other losses. The company maintained compliance with debt covenants and increased cash and cash equivalents to $21.4 million.

Key Highlights

  • Q2 2026 sales decreased 2.6% to $464.1 million.
  • Q2 2026 net income fell 36.2% to $23.6 million.
  • Basic EPS for Q2 2026 was $0.69, down from $1.06.
  • Six-month net income rose to $40.1 million from $14.5 million.
  • Cash and cash equivalents increased to $21.4 million.
  • Long-term debt stood at $1.24 billion as of July 3, 2026.
  • Net cash from operating activities was $84.4 million for six months.
  • Repurchased $50.0 million of common stock in six months.